Oct. 11, 2012—Sarah H. Sell, M.D., professor of Pediatrics, Emerita, one of the key players in the development of the childhood vaccine to protect against Haemophilus influenzae type b (Hib), the most common cause of bacterial meningitis in children younger than 5, died Saturday, Oct. 6. She was 99.
Oct. 11, 2012—Vanderbilt’s Bill Wilkerson Center and the Department of Hearing and Speech Sciences are offering new interdisciplinary outpatient programs for children ages 3 to 21 who have experienced a traumatic brain injury (TBI).
Oct. 11, 2012—Vanderbilt University scientists are cheering this year’s Nobel Prize in Medicine for recognizing the discovery that mature cells can be “reprogrammed” into other cell types — a finding which they said has electrified their work.
Oct. 11, 2012—When patients come to Vanderbilt’s new Center for Medical Weight Loss, the first thing medical director John Cleek, M.D., wants them to understand is how their bodies use energy.
Oct. 11, 2012—A ribbon-cutting ceremony and open house was held Tuesday for the Vanderbilt Franklin Women’s Center at Williamson Medical Center (formerly known as the Franklin Women’s Center).
Oct. 11, 2012—Mammograms can be as easy as TVC.
Oct. 11, 2012—An upcoming issue of the journal Nature Biotechnology announces the release of ProteoWizard Toolkit 3.0, a free set of cross-platform (PC, Mac, Linux) software libraries and applications designed to facilitate proteomics research. The article is now available on the journal’s website.
Oct. 11, 2012—James Netterville, M.D., professor of Otolaryngology and director of the Head and Neck Surgical Oncology Service, has been elected president of the American Academy of Otolaryngology – Head and Neck Surgery (AAO-HNS) and its foundation for the 2012-13 term. He assumed his position in September during the annual meeting in Washington, D.C.
Oct. 11, 2012—The skies cleared and the sun shone on the 2012 Nashville Heart Walk that took place on Vanderbilt’s campus on Saturday.
Oct. 11, 2012—Vanderbilt is taking part in a national study to test in older adults the use of a vaccine designed to protect children against a common cause of pneumonia.